Papers
2
Total Citations
17
H-Index
2
About
Yu-gen Li is a rising authority in minimally invasive urologic oncology, with a focused expertise in robotic and laparoscopic surgery for complex renal and adrenal tumors. His research systematically evaluates the safety and efficacy of advanced surgical techniques, particularly for challenging cases. In a landmark 2023 evidence-based analysis, Dr. Li demonstrated that robot-assisted partial nephrectomy (RAPN) for special tumor types—including hilar, endophytic, and cystic renal masses—achieves comparable perioperative, oncologic, and functional outcomes to those for non-complex tumors, providing crucial data that expands the indications for nephron-sparing surgery. This work, already cited 12 times, is foundational for surgeons managing high-complexity cases. Additionally, his pooled analysis comparing robotic versus laparoscopic posterior retroperitoneal adrenalectomy (cited 5 times) clarifies the benefits of the robotic approach, including reduced blood loss and shorter hospital stays. By synthesizing global evidence through rigorous meta-analyses, Dr. Li is shaping best-practice guidelines and helping define the evolving role of robotics in urologic surgery. His contributions are particularly valuable for trainees and clinicians seeking evidence-based strategies to optimize outcomes in technically demanding procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2